Literature DB >> 22645076

Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines.

Rebecca A Levine1, Bhani Chawla, Shelli Bergeron, Harry Wasvary.   

Abstract

PURPOSE: Multidisciplinary teams have become increasingly desirable for managing complex disease but little objective data exist to support this approach. The aim of our study was to determine the impact of a multidisciplinary clinic on the management of colorectal cancer.
METHODS: Data were prospectively collected on all patients with newly diagnosed colorectal cancer referred to the multidisciplinary clinic at our institution in 2009 and compared to a control group of all patients managed outside the clinic from 2008 to 2009. Comprehensiveness of preoperative evaluation was determined by frequency of abdominal and chest CT, CEA testing, and transrectal ultrasound. Access to multimodal care was measured by frequency of oncology consultation and treatment, advanced pathology testing, genetics counseling, and trial enrollment.
RESULTS: Two hundred eighty-eight patients met inclusion criteria; 88 patients were referred to the clinic (40 preoperative, 48 postoperative) and 200 patients were managed outside. Complete preoperative evaluation was accomplished three times more frequently in clinic patients (85 vs. 23 %, p < 0.0001) with significant improvements in all parameters. Enhanced access to multimodal therapy was demonstrated in clinic patients by increased frequency of oncology consultation (98.9 vs. 61.5 %, p < 0.0001) and treatment (62.5 vs. 41.5 %, p = 0.02), advanced pathology testing (29.6 vs. 10.6 %, p = 0.0001), and genetics counseling (6.8 vs. 1.6 %, p = 0.28). Clinic patients also received significantly higher rates of neoadjuvant therapy for stage II or greater rectal cancer (82.6 vs. 30.9 %, p = 0.0001).
CONCLUSIONS: Multidisciplinary clinic management of colorectal cancer is associated with a significantly more complete preoperative evaluation as well as improved access to multimodal therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22645076     DOI: 10.1007/s00384-012-1501-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  35 in total

1.  Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit.

Authors:  K Smedh; L Olsson; H Johansson; C Aberg; M Andersson
Journal:  Br J Surg       Date:  2001-02       Impact factor: 6.939

2.  Cancer patient survival improvement is correlated with the opening of a community cancer center: comparisons with intramural and extramural benchmarks.

Authors:  Robert O Dillman; Sherri D Chico
Journal:  J Oncol Pract       Date:  2005-09       Impact factor: 3.840

3.  Surgeon-related factors and outcome in rectal cancer.

Authors:  G A Porter; C L Soskolne; W W Yakimets; S C Newman
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

4.  Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03.

Authors:  Mark S Roh; Linda H Colangelo; Michael J O'Connell; Greg Yothers; Melvin Deutsch; Carmen J Allegra; Morton S Kahlenberg; Luis Baez-Diaz; Carol S Ursiny; Nicholas J Petrelli; Norman Wolmark
Journal:  J Clin Oncol       Date:  2009-09-21       Impact factor: 44.544

5.  Total mesorectal excision in the operative treatment of carcinoma of the rectum.

Authors:  W E Enker; H T Thaler; M L Cranor; T Polyak
Journal:  J Am Coll Surg       Date:  1995-10       Impact factor: 6.113

6.  Surgeon specialty is associated with outcome in rectal cancer treatment.

Authors:  Thomas E Read; Robert J Myerson; James W Fleshman; Robert D Fry; Elisa H Birnbaum; Bruce J Walz; Ira J Kodner
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

7.  Rectal cancer patients benefit from implementation of a dedicated colorectal cancer center in a Veterans Affairs Medical Center.

Authors:  Jonathan A Wilks; Catherine Liebig; Syed H Tasleem; Kujtim Haderxhanaj; Liz Lee; Buckminster Farrow; Samir Awad; David Berger; Daniel Albo
Journal:  Am J Surg       Date:  2009-03-06       Impact factor: 2.565

8.  Management of ovarian cancer: referral to a multidisciplinary team matters.

Authors:  E J Junor; D J Hole; C R Gillis
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

9.  An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.

Authors:  L M Forrest; D C McMillan; C S McArdle; D J Dunlop
Journal:  Br J Cancer       Date:  2005-10-31       Impact factor: 7.640

10.  The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's colorectal cancer patients.

Authors:  E Morris; R A Haward; M S Gilthorpe; C Craigs; D Forman
Journal:  Br J Cancer       Date:  2006-10-23       Impact factor: 7.640

View more
  17 in total

Review 1.  Reviewing cancer care team effectiveness.

Authors:  Stephen H Taplin; Sallie Weaver; Eduardo Salas; Veronica Chollette; Heather M Edwards; Suanna S Bruinooge; Michael P Kosty
Journal:  J Oncol Pract       Date:  2015-04-14       Impact factor: 3.840

2.  Multidisciplinary Clinic Management of Head and Neck Cancer.

Authors:  Melanie Townsend; Dorina Kallogjeri; Nicholas Scott-Wittenborn; Katherine Gerull; Stacy Jansen; Brian Nussenbaum
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-12-01       Impact factor: 6.223

3.  Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.

Authors:  Lauren C Harshman; Abhishek Tripathi; Matthew Kaag; Jason A Efstathiou; Andrea B Apolo; Jean H Hoffman-Censits; Walter M Stadler; Evan Y Yu; Bernard H Bochner; Eila C Skinner; Tracy Downs; Anne E Kiltie; Dean F Bajorin; Khurshid Guru; William U Shipley; Gary D Steinberg; Noah M Hahn; Srikala S Sridhar
Journal:  Clin Genitourin Cancer       Date:  2017-12-06       Impact factor: 2.872

4.  Use and Effectiveness of Adjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer in Men.

Authors:  Sriram Venigalla; Ruben Carmona; David M Guttmann; Varsha Jain; Gary M Freedman; Amy S Clark; Jacob E Shabason
Journal:  JAMA Oncol       Date:  2018-10-11       Impact factor: 31.777

5.  Assessing the feasibility of a virtual tumor board program: a case study.

Authors:  Christopher M Shea; Randall Teal; Lindsey Haynes-Maslow; Molly McIntyre; Bryan J Weiner; Stephanie B Wheeler; Sara R Jacobs; Deborah K Mayer; Michael Young; Thomas C Shea
Journal:  J Healthc Manag       Date:  2014 May-Jun

6.  Multidisciplinary clinic in the management of hepatocellular carcinoma.

Authors:  Kevin C Soares; David C Cosgrove; Joseph M Herman; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2013-12-07       Impact factor: 5.344

7.  Multidisciplinary cancer conferences for gastrointestinal malignancies result in measureable treatment changes: a prospective study of 149 consecutive patients.

Authors:  Jacqueline Oxenberg; Wesley Papenfuss; Iyare Esemuede; Kristopher Attwood; Marko Simunovic; Boris Kuvshinoff; Valerie Francescutti
Journal:  Ann Surg Oncol       Date:  2014-10-17       Impact factor: 5.344

Review 8.  The multidisciplinary management of rectal cancer.

Authors:  Deborah S Keller; Mariana Berho; Rodrigo O Perez; Steven D Wexner; Manish Chand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-12       Impact factor: 46.802

9.  Laparo-endoscopic transgastric resection of gastric submucosal tumors.

Authors:  Juan S Barajas-Gamboa; Geylor Acosta; Thomas J Savides; Jason K Sicklick; Syed M Abbas Fehmi; Alisa M Coker; Shannon Green; Ryan Broderick; Diego F Nino; Cristina R Harnsberger; Martin A Berducci; Bryan J Sandler; Mark A Talamini; Garth R Jacobsen; Santiago Horgan
Journal:  Surg Endosc       Date:  2014-10-11       Impact factor: 4.584

10.  Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.

Authors:  Bobby Daly; Olufunmilayo I Olopade; Ningqi Hou; Katharine Yao; David J Winchester; Dezheng Huo
Journal:  JAMA Oncol       Date:  2017-07-01       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.